NSECertificate under SEBI (Depositories and Participants) Regulations, 20186 Oct 2026 · 6 Oct 2026, 07:00 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Thyrocare Technologies Limited · THYROCARE
✦ AI Summary
Thyrocare Technologies Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming that the company's shares are in demat form and no requests for rematerialization were received during the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Thyrocare Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026
Attachments (1)
📄pdf
Download →
THYROCARE_06102026185952_SE_74_5_Signed.pdf
View document text
0 Thyrocare
Tests you can trust
October 06, 2026
National Stock Exchange of India Limited BSE Ltd.
Exchange Plaza Phiroze Jeejeebhoy Towers
Bandra Kurla Complex, Dalal Street,
Bandra (E), Mumbai - 400051 Mumbai- 400 001
(SYMBOL: THYROCARE) (SCRIP CODE: 539871)
Sub: Intimation under Regulation 74(5) of SEBI (Depositories and Participants)
Regulations, 2018 for the Quarter ended September 30, 2026
Dear Sir/Madam
Pursuant to regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018,
please find enclosed herewith the Certificate for the Quarter ended September 30, 2026,
duly certified by Registrar and Share Transfer Agent confirming the requirements.
You are requested to kindly take the same on record.
Yours faithfully
For Thyrocare Technologies Limited
Brijesh Kumar
Company Secretary and Compliance Officer
Encl: A/a
Thyrocare Technologies Limited
9 D-37/1, TTC MIDC, Turbhe, Navi Mumbai-400 703, India (9 022-3090 0000
i.':'ii info@thyrocare.com (@ www.thyrocare.com
(CIN : L86905MH2000PLC123882)
@ MUFG
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400 083
Phone: +91 22 4918 6000
Website: in.mpms.mufg.com
To, Date: 06-10-2026
The Compliance Officer/ Company Secretary
THYROCARE TECHNOLOGIES LIMITED
D/37-1, TTC INDUSTRIAL AREA
MIDC TURBHE
NAVI MUMBAI - 400703
MAHARASHTRA
Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended
September 30th, 2026.
Dear Sir/Madam,
With reference to the captioned regulation, we hereby confirm that the said Regulation is not applicable to the Company, as
the entire holding of the Company’s shares are in demat form, and we have not received any request from any members of
the Company for rematerialisation during the quarter ended on September 30th, 2026.
We request you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
Ashok Shetty
Sr. Vice President-Corporate Registry